Compare IRON & KN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | KN |
|---|---|---|
| Founded | 2017 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.0B |
| IPO Year | 2020 | 2013 |
| Metric | IRON | KN |
|---|---|---|
| Price | $69.83 | $40.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 3 |
| Target Price | ★ $103.18 | $28.00 |
| AVG Volume (30 Days) | 384.6K | ★ 928.9K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 118.94 |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $593,200,000.00 |
| Revenue This Year | N/A | $9.40 |
| Revenue Next Year | $283.52 | $6.98 |
| P/E Ratio | ★ N/A | $376.09 |
| Revenue Growth | N/A | ★ 7.17 |
| 52 Week Low | $40.00 | $16.94 |
| 52 Week High | $99.50 | $41.47 |
| Indicator | IRON | KN |
|---|---|---|
| Relative Strength Index (RSI) | 54.12 | 65.53 |
| Support Level | $64.48 | $23.97 |
| Resistance Level | $71.85 | N/A |
| Average True Range (ATR) | 3.26 | 1.70 |
| MACD | 0.04 | 0.07 |
| Stochastic Oscillator | 64.61 | 73.32 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.